Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT06268977
PHASE4
Adding SGLt2 Inhibitors to Patients With Type 2 Diabetes
Sponsor: Assiut University
View on ClinicalTrials.gov
Summary
To detect the efficacy of SGLT2i in improving the metabolic parameters in patients with type 2 diabetes. \- To detect the side-effects of SGLT2i
Official title: Efficacy and Safety of Incorporating Sodium-glucose Cotransporter-2 Inhibitors to Regimens of Patients With Type 2 Diabetes
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
482
Start Date
2025-04-01
Completion Date
2026-01-30
Last Updated
2026-09-10
Healthy Volunteers
No
Conditions
Interventions
DRUG
SGLT2 inhibitor
a class of prescription medicines that are FDA-approved for use with diet and exercise to lower blood sugar in adults with type 2 diabetes.
Locations (1)
Assiut University Hospital
Asyut, Egypt